Development of a vesicular system for effective ocular delivery of acetazolamide A comprehensive approach and successful venture

Journal of Drug Delivery Science and Technology

Volumn 17, Issue 1, 2007, Pages 33-41

  Kaur, I P ^a   Mitra, A K ^b   Aggarwal, D ^a  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Acetazolamide; Bioadhesive; Challenge test; Corneal penetration; Cytotoxicity; Introcular pressure; Microdialysis; Niosomes; Stability; Topical preparation

Indexed keywords

ACETAZOLAMIDE; BENZALKONIUM CHLORIDE; BORIC ACID; CARBOMER; DORZOLAMIDE; DORZOX; NIOSOME; NONIONIC SURFACTANT; PERBORATE SODIUM; POLYSORBATE 80; PRESERVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; CYTOTOXICITY; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG STABILITY; EVAPORATION; INTRAOCULAR PRESSURE; NONHUMAN; PH; RABBIT;

EID: 33847340168     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(07)50005-5     Document Type: Article

References (55)

1. Kaur I. P., Smitha R., Aggarwal D., Kapil M. - Acetazolamide: future perspective in topical glaucoma therapeutics. - Int. J. Pharm., 248, 1-14, 2002.
2. Le Bourlias C. A., Treupel-Acar L., Rhodes C. T., Sado P. A., Leverge R. - New ophthalmic drug delivery systems. - Drug Dev. Ind. Pharm., 21, 19-59, 1995.
3. Shell J. W., Baker R. - Diffusional system for controlled release to the eye. - Ann. Ophthalmol., 6, 1037-1043, 1974.
4. Burstein N. L., Anderson J. A. - Review: Corneal penetration and ocular availability of drugs. - J. Ocul. Pharmacol., 1, 309-326, 1985.
5. Shell J. W. - Ophthalmic drug delivery systems. - Surv. Ophthalmol., 29, 117-128, 1984.
6. Reddy I.K., Ganeshan M.G. - Ocular therapeutics and drug delivery: an overview. - In: Ocular Therapeutics and Drug Delivery: A Multidisciplinary Approach, I.K. Reddy Ed., Technomic Publishing Company, Philadelphia, USA, 1996, pp. 3-29.
7. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. - The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. - Arch. Ophthalmol., 120, 701-713, 2002.
8. Maren T.H. - Carbonic anhydrase: Chemistry, physiology and inhibition. - Physiol. Rev., 47, 595-597, 1967.
9. Maren T.H. - Carbonic anhydrase: General prospectives and advances in glaucoma research. - Drug Dev. Res., 10, 255-276, 1987.
10. Supuran C.T., Scozzafava A. - Carbonic anhydrase inhibitors and their therapeutic potential. - Exp. Opin. Ther. Patents, 10, 575-600, 2000.
11. Supuran C.T., Scozzafava A. - Application of carbonic anhydrase inhibitors and activators in therapy. - Expert Opin. Ther. Patents, 14, 1-104, 2002.
12. Epstein D.L., Grant W.M. - Carbonic anhydrase inhibitor side effects. - Arch Opthamol., 95, 1378-1382, 1977.
13. Gamm E. - Origination of side effects of acetazolamide. - Glaucoma, 6, 60-63, 1984.
14. Singla A.K., Kaurl P., Garg A., Aggarwal D. - Novel approaches for topical delivery of acetazolamide. - Pharm Tech., 26, 24-34, 2002.
15. Duffel M.W., Ing I.S., Segarra T.M., Dixson J.A., Barfknecht C.F., Schoenwald R.D. - Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure. - J. Med. Chem., 29, 1488-1494, 1986.
16. Parasrampuria J. - Acetazolamide. - In: Analytical Profile of Drug Substances, H.G. Brittains Ed., 1, Academic Press, New York, 1993, pp. 1-28.
17. Furrer P., Plazonnet B., Mayer J.M., Gurny R. - Application of in vivo confocal microscopy to the objective evaluation of occular irritation induced by surfactants. - Int. J. Pharm., 207, 89-98, 2000.
18. Majumdar S., Tirucheri G.S., Pal D., Mitra A.K. - Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea. - AAPS Pharm. Sci., 5, 145-158, 2003.
19. Goskonda V.R., Khan M.A., Hutak C.M., Reddy I.K. - Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells. - J. Pharm. Sci., 88, 180-184, 1999.
20. Tak R.V., Pal D., Gao H., Dey S., Mitra A.K. - Transport of acyclovir easter prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. - J.Pharm. Sci., 190, 1505-1515, 2001.
21. Blondin C., Hamard P., Cholley B., Haeffner-Cavaillon N., Baudouin C. - In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system. - Curr. Eye Res., 27, 253-259, 2003.
22. Boudouin C. - Side effcets of antiglaucomatous drugs on the ocular surface. - Curr. Opin. Ophthalmol., 7, 80-86, 1996.
23. Baudouin C. - Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs? - Int. J. Clin. Pharmacol. Res., 16, 29-41, 1996.
24. Ishibashi T., Yokoin., Kinoshi S. - Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. - J. Glaucoma, 12, 486-490, 2003.
25. Gasset A.R., Ishii Y., Kaufman H.E., Miller T. - Cytotoxicity of ophthalmic preservatives. - Am. J. Ophthalmol., 78, 98-105, 1974.
26. Pisella P.J., Fillacier K., Elena P.P., Debbasch C., Baudouin C. - Comparison of the effects of preserved and unpreserved formulations of timolol in the ocular surface of albino rabbits. - Ophthalmic Res., 32, 3-8, 2000.
27. Nocker R. - Effects of common ophthalmic preservatives on ocular health. - Adv. Ther., 18, 205-215, 2001.
28. British Pharmacopoeia. - In: British Pharmacopoeia, II, The Stationary Office, London, 1999, A266-A268.
29. Aggarwal D., Garg A.,Kaurl.P. - Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. - J.Pharm. Pharmacol., 56, 1509-1517, 2004.
30. Indian Pharmacopoeia. - Controller of Publication, Delhi, 2, Appendix 9.5, 1996 A117-A124.
31. Barltrop J.A. - 5-(3-carboxymethoxyphenyl)-2-(4,5-dimenthylthiazoly)-3- (4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans a cell-viability indicators. - Bioorg. & Med. Chem. Lett., 1, 611, 1991.
32. Riss T.L., Moravec R.A. - Comparison of MTT, XTT, and a novel tetrazolium compound for MTS for in vitro proliferation and chemosensitivity assays. - Mol. Biol. Cell (Suppl.), 3, 184a, 1992.
33. The Merck Index. - In: Merck and Co., Windholz M., NY, 1983, 8492.
34. Indian Pharmacopoeia. - Controller of Publication, Delhi, 1, 1996, 21.
35. Gould-Fogerite S., Mannino R.J. - Preparation of large unilamellar liposomes with high entrapment yield by rotary dialysis or agarose plug diffusion. - In: Liposome Technology: Liposome Preparation and Related Techniques, G. Gregoridis Ed., CRC Press, Boca Raton, 1992, pp. 68-79.
36. Lehr C.M., Lee Y.H., Lee V.H. - Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. - Invest Ophthalmol. Vis. Sci., 35, 2809-2814, 1994.
37. Hecht G. - Ophthalmic preparations. - In: Remington: The Science and Practice of Pharmacy, A.R. Gennaro Ed., Lipincott Williams and Wilkins, USA, 2001, pp. 821-833.
38. Riegelman S., Sorby D.L. - EENT preparations. - In: Husa's Pharmaceutics, E.W. Martin and J.E. Hoover Eds., Mack Publishing Company, Easton, PA, 1966, pp. 311-356.
39. Moses (Ed.). - Alder's Physiology of the Eye. - Mosby, St. Louis, USA, 1981.
40. Surgue M.F. - The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. - J. Ocul. Pharmacol. Ther, 12, 363-376, 1996.
41. Ponticello G.S., Surgue M.F., Plazonnet B., Durand-Cavagna G. - Dorzolamide, a 40-year wait from an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma. - In: Integration of Discovery and Development: Case Studies, Borchardt, Plenum Press, 1998, pp. 555-574.
42. FriedLand B.R., Mallonee J., Anderson D.R. - Short-term dose response characteristics of acetazolamide in man. - Arch. Ophthalmol., 95, 1809-1812, 1977.
43. Alm A., Berggren L., Hartvlig P., Roosdrop M. - Monitoring acetazolamide treatment. - Acta ophthalmol., 60, 24-34, 1982.
44. Lehmann B., Linner E., Wristrand P.J. - The pharmacokinetics of acetazolamide in relation to its use in the treatment of glaucoma and to its effects as an inhibitor of carbonic anhydrases. - In: Schering Workshop in Pharmacokinetics, Advances in the Biosciences, G. Rospe Ed., Pergamon, New York, 1969, pp. 197-217.
45. Berson F.G., Epstein D.L., Grant W.M., Hutchinson B.T., Dobbs P.C. - Acetazolamide dosage forms in the treatment of glaucoma. - Arch. Ophthalmol., 98, 1051-1054, 1980.
46. Lukyanov A.N., Torchilin V.P. - Autoclaving of liposomes. - J. Microencapsul., 11, 669-672, 1994.
47. Agarwal R., Katare O.P., Vyas S.P. - Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. - Int. J. Pharm., 228, 43-52, 2001.
48. Patel V.B., Misra A.N. - Encapsulation and stability of clofazamine liposomes. - J. Microencapsul., 16, 357-367, 1999.
49. Peer D., Florentin A., Margalit R. - Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. - Biochimica et Biophysica Acta (BBA) Biomembranes, 1612, 76-82, 2003.
50. Debbasch C., De La Salle S.B., Brignole F., Rat P., Warnet J.M., Baudouin C. - Cytoprotective effects of hyaluronic aced and carbomer 934P in ocular surface epithelial cells. - Invest Ophthalmol. Vis. Sci., 43, 3409-3415, 2002.
51. Curren R.D., Harbell J.W. - In vitro alternatives for ocular irritation. - Experimental Health Perspectives, 106, 485-492, 1998.
52. Kaur I.P., Smitha R. - Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. - Drug Dev. Ind. Pharm., 28, 353-369, 2002.
53. Paugh J.R., Brennan N.A., Efron N. - Ocular response to hydrogen peroxide. - Am. J. Optom. Physiol. Opt., 65, 91-98, 1988.
54. Pisella P.J., Fillacier K., Elena P.P., Debbasch C., Baudouin C. - Comparison of the effects of preserved and unpreserved formulations of timolol in the ocular surface of albino rabbits. - Ophthalmic Res., 32, 3-8, 2000.
55. Vareilles P., Silverstone D., Plazonnet B., Le Douaree J.C., Sears M.L., Stone C.A. - Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit. - Invest Ophthalmol. Vis. Sci., 16, 987, 1977.